Ticker

Analyst Price Targets — OFIX

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
November 5, 2025 2:21 pmMichael PetuskyBarrington$18.00$14.81TheFly Orthofix price target raised to $18 from $17 at Barrington
October 28, 2025 10:51 amStifel Nicolaus$22.00$16.12TheFly Orthofix resumed with a Buy at Stifel
November 8, 2024 8:01 amMathew BlackmanStifel Nicolaus$24.00$18.22StreetInsider Stifel Upgrades Orthofix International (OFIX) to Buy
June 28, 2022 1:47 pmMathew BlackmanStifel Nicolaus$31.00$24.12TheFly Stifel cuts Orthofix target, says momentum 'faded' during Q2

Latest News for OFIX

Orthofix Medical (NASDAQ:OFIX) Shares Gap Up Following Insider Buying Activity

Orthofix Medical Inc. (NASDAQ: OFIX - Get Free Report) shares gapped up prior to trading on Friday after an insider bought additional shares in the company. The stock had previously closed at $13.17, but opened at $13.79. Orthofix Medical shares last traded at $13.4610, with a volume of 77,899 shares traded. Specifically, major shareholder Engine Capital

Defense World • Feb 28, 2026
Orthofix (OFIX) Q4 Earnings and Revenues Lag Estimates

Orthofix (OFIX) came out with quarterly earnings of $0.26 per share, missing the Zacks Consensus Estimate of $0.44 per share. This compares to earnings of $0.02 per share a year ago.

Zacks Investment Research • Feb 24, 2026
Orthofix Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today reported its financial results for the fourth quarter and full-year ended December 31, 2025, provided full-year 2026 financial guidance and updated its three-year financial targets. All pro forma measures contained within this release exclude the impact of the Company's decision to discontinue…

Business Wire • Feb 24, 2026
Orthofix to Participate in Upcoming Investor Conferences

LEWISVILLE, Texas--(BUSINESS WIRE)--Orthofix Medical Inc. (NASDAQ:OFIX), a leading global medical technology company, today announced that Massimo Calafiore, President and Chief Executive Officer, and Julie Andrews, Chief Financial Officer, will participate in the following investor conferences: Canaccord Genuity 2026 Musculoskeletal Conference - New Orleans, March 2, 2026, 9:30 am CT TD Cowen 46th Annual Health…

Business Wire • Feb 10, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for OFIX.

No House trades found for OFIX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top